Alyssa M. Roberts BS , Danielle West BS , Benjamin Stroebel MPH , Katrina Abuabara MD, MA, MSCE
{"title":"Evaluating the psychosocial burden and unmet needs for health care access among older adults with inflammatory skin disease","authors":"Alyssa M. Roberts BS , Danielle West BS , Benjamin Stroebel MPH , Katrina Abuabara MD, MA, MSCE","doi":"10.1016/j.jdin.2024.11.006","DOIUrl":"10.1016/j.jdin.2024.11.006","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 174-176"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matthew Penna MD, PhD , Lauren Pupa MD , Grace Lee MD , Soo Jung Kim MD, PhD
{"title":"Skin manifestations and related clinical characteristics of multisystem inflammatory syndrome in children: A descriptive retrospective cohort study at Texas Children’s Hospital","authors":"Matthew Penna MD, PhD , Lauren Pupa MD , Grace Lee MD , Soo Jung Kim MD, PhD","doi":"10.1016/j.jdin.2024.09.009","DOIUrl":"10.1016/j.jdin.2024.09.009","url":null,"abstract":"<div><h3>Background</h3><div>Little is known about the dermatologic manifestations of multisystem inflammatory syndrome in children (MIS-C) in children and adolescents.</div></div><div><h3>Objective</h3><div>We sought to describe the demographic background, key clinical features, and the clinical consequences of developing rash manifestations in MIS-C patients at Texas Children’s Hospital.</div></div><div><h3>Methods</h3><div>Descriptive retrospective cohort study of 290 hospitalized eligible patients between May 2020 and April 2022.</div></div><div><h3>Results</h3><div>Among MIS-C patients, 51% exhibited a rash. We found that younger children (8.62 vs 9.49 years of age, <em>P</em> = .006) and White children (<em>P</em> = .002) had a higher likelihood of developing a rash in association with MIS-C. Additionally, patients without a rash had increased maximum troponin levels (0.11 ng/mL vs 0.07 ng/mL, <em>P</em> = .02) and a higher incidence of cardiac involvement (83.1% vs 72.3%, <em>P</em> = .03) compared to those with a rash but did not significantly affect the length of hospital stay or clinical course. The most commonly observed rash was an erythematous and maculopapular rash on the trunk and/or extremities.</div></div><div><h3>Limitations</h3><div>Rash characteristics were initially described by a variety of physicians in the pediatric primary care services.</div></div><div><h3>Conclusion</h3><div>Rash manifestations in MIS-C patients are associated with lower cardiac involvement and decreased troponin levels.</div></div>","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 122-127"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11667042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142885390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chapman Wei MD , Ahmad Mustafa MD , Radu Grovu MD , Angela Rosenberg DO , Alaukika Agarwal MD , Alanna Davis MD , Nawal Mustafa MD , Stefan Bradu MD , Suzanne El-Sayegh MD
{"title":"Atopic dermatitis increases the risk of infective endocarditis in prosthetic heart valve patients – A retrospective study","authors":"Chapman Wei MD , Ahmad Mustafa MD , Radu Grovu MD , Angela Rosenberg DO , Alaukika Agarwal MD , Alanna Davis MD , Nawal Mustafa MD , Stefan Bradu MD , Suzanne El-Sayegh MD","doi":"10.1016/j.jdin.2024.09.016","DOIUrl":"10.1016/j.jdin.2024.09.016","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 140-141"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sheyda Mesgarzadeh BS , Caitlyn N. Myrdal MD , Amanda H. Gong BS , Delaney B. Stratton PhD, DNP, FNP-BC , Brenna G. Kelly MD , Clara Curiel-Lewandrowski MD
{"title":"Heterogeneity among melanoma databases and challenges in sustainability: A survey of the Melanoma Prevention Working Group","authors":"Sheyda Mesgarzadeh BS , Caitlyn N. Myrdal MD , Amanda H. Gong BS , Delaney B. Stratton PhD, DNP, FNP-BC , Brenna G. Kelly MD , Clara Curiel-Lewandrowski MD","doi":"10.1016/j.jdin.2024.02.001","DOIUrl":"10.1016/j.jdin.2024.02.001","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 137-139"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139824137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of disease cyclicity on quality-of-life impairment—A mixed method explanatory study","authors":"Ying Shan Cheung MD , Winston Tham Zhi Wen , Ashvin R. Chundayil , Phillip Phan PhD , Ellie Choi Ci-En MBBS, MRCP","doi":"10.1016/j.jdin.2024.09.007","DOIUrl":"10.1016/j.jdin.2024.09.007","url":null,"abstract":"<div><h3>Background</h3><div>Disease cyclicity, a composite measure of unpredictable and daily fluctuations of symptoms, strongly predicts quality-of-life (QoL) impairment.</div></div><div><h3>Objective</h3><div>To explore the mechanisms by which cyclicity impacts QoL.</div></div><div><h3>Methods</h3><div>1:1 semi-structured interviews were conducted and qualitatively analyzed using grounded theory. Common themes were identified and used to derive a theoretical framework.</div></div><div><h3>Results</h3><div>Twenty-three adults, (median age 28.5, range 20-72) with a range of chronic inflammatory diseases including eczema, psoriasis, and inflammatory arthritis were prospectively recruited. Cyclicity, characterized by unpredictability, uncontrollability, and lability, contributed to a varying productivity and inconsistent ability in performing daily activities. Challenges intensified if external expectations of the patient were inconsistent with their fluctuating ability. Coping abilities, shaped by internal and external factors, moderated the relationship between cyclicity and QoL impairment.</div></div><div><h3>Limitations</h3><div>Qualitative interviews assume patients have accurate insights into their own behaviors. The generalizability of findings may be limited in other populations.</div></div><div><h3>Conclusion</h3><div>Disease cyclicity defines many inflammatory diseases. This study provides a theoretical framework for understanding and managing the challenges patients with a cyclical condition face.</div></div>","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 180-187"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11751501/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Isufi BSc(Med) , Mikkel Bak Jensen MD , Nikolai Loft MD, PhD , Lone Skov MD, PhD, DMSc , Jesper Elberling MD, PhD , Farzad Alinaghi MD, PhD
{"title":"Risk of infections during treatment with oral Janus kinase inhibitors in randomized placebo-controlled trials: A systematic review and meta-analysis","authors":"Daniel Isufi BSc(Med) , Mikkel Bak Jensen MD , Nikolai Loft MD, PhD , Lone Skov MD, PhD, DMSc , Jesper Elberling MD, PhD , Farzad Alinaghi MD, PhD","doi":"10.1016/j.jdin.2024.09.012","DOIUrl":"10.1016/j.jdin.2024.09.012","url":null,"abstract":"<div><div>Janus kinase (JAK) inhibitors block pathways involved in inflammation and immune response, making JAK inhibitors useful in the treatment of various diseases. While the efficacy of these drugs has been proven in several studies, their safety profile needs to be further investigated. In this systematic review and meta-analysis, we examined the risk of infections during treatment with oral JAK inhibitors with no concomitant treatment compared to placebo in phase 2 and 3 randomized, placebo-controlled trials. The medical databases PubMed, Web of Science, and EMBASE were searched from inception through February 2024, yielding 13,567 nonduplicate articles, of which 69 were included in the final quantitative analysis. Overall, we found that treatment with oral JAK inhibitors was associated with an increased risk of infections compared to placebo across all indications (relative risk: 1.39 [95% CI: 1.096-1.76, <em>P</em> = .0067]) and in dermatologic indications (relative risk: 1.46 [95% CI, 1.10-1.93, <em>P</em> = .0097]). Remarkably, an increased risk of herpes zoster infections was found in dermatologic indications but not in nondermatologic indications. In conclusion, we identified a significantly increased risk of developing infections during treatment with oral JAK inhibitors compared to placebo across indications. In sub-analyses, we additionally found an increased risk of herpes zoster in dermatologic indications.</div></div>","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 106-116"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664075/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elise M. Cai BS, Pirunthan Pathmarajah MD, Roxana Daneshjou MD, PhD, Justin M. Ko MD, MBA, Albert S. Chiou MD, MBA
{"title":"Evaluating the appropriateness of skin cancer prevention recommendations obtained from an online chat-based artificial intelligence model","authors":"Elise M. Cai BS, Pirunthan Pathmarajah MD, Roxana Daneshjou MD, PhD, Justin M. Ko MD, MBA, Albert S. Chiou MD, MBA","doi":"10.1016/j.jdin.2024.07.028","DOIUrl":"10.1016/j.jdin.2024.07.028","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 145-147"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael S. Chang MD , Jordan T. Said MD , Elliot H. Akama-Garren PhD , Nicole Trepanowski MD , Ai-Tram N. Bui MD , Anita Giobbie-Hurder MS , Nicole R. LeBoeuf MD, MPH , Rebecca I. Hartman MD, MPH
{"title":"NRAS tumor mutations are associated with reduced odds of dermatologic adverse events in patients with metastatic melanoma receiving immune checkpoint inhibitors","authors":"Michael S. Chang MD , Jordan T. Said MD , Elliot H. Akama-Garren PhD , Nicole Trepanowski MD , Ai-Tram N. Bui MD , Anita Giobbie-Hurder MS , Nicole R. LeBoeuf MD, MPH , Rebecca I. Hartman MD, MPH","doi":"10.1016/j.jdin.2024.11.004","DOIUrl":"10.1016/j.jdin.2024.11.004","url":null,"abstract":"","PeriodicalId":34410,"journal":{"name":"JAAD International","volume":"18 ","pages":"Pages 165-167"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}